NCT06696846
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Clinical trial condition
Lymphoma, T-Cell
Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.
181 public trials
52 recruiting studies
Lymphoma, T-Cell trial results
NCT06854653
- Conditions
- CTCL, Disease Attributes, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- City of Hope Comprehensive Cancer Cente Duarte, California, United States
- University of California Irvine Irvine, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT05984147
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Omega Cancer Hospitals Visakhapatnam, Andhra Pradesh, India
- Post Graduate Institute of Medical Education & Research, Chandigarh, India
- Cellcure Care Cancer Pvt Ltd Ahmedabad, Gujarat, India
- HCC Happiness Care and Cure Multispeciality Hospital Ahmedabad, Gujarat, India
Recruiting
Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-DOU3)
NCT07496229
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
- Henan Provincial People's Hospital Zhengzhou, Henan, China
NCT07356245
- Conditions
- Adult T-Cell Leukemia/Lymphoma, Cutaneous T Cell Lymphoma, Graft Versus Host Disease, +25 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Recruiting
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
NCT05996185
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +19 more
- Locations
-
- Yale Cancer Center, Clinical Trials Office New Haven, Connecticut, United States
- Icahn School of Medicine at Mount Sinai New York, United States
NCT05010005
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
- Locations
-
- University of Miami (Data Collection Only) Miami, Florida, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
NCT06561048
- Conditions
- Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of California, Irvine Irvine, California, United States
- University of California San Francisco San Francisco, California, United States
- Yale University New Haven, Connecticut, United States
NCT06756308
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Dana Farber Cancer Institute (Data Collection Only) Boston, Massachusetts, United States
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
NCT07270861
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China